RecruitingPhase 2NCT03253263
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- OHB Neonatology Ltd.
- Intervention
- OHB-607(drug)
- Enrollment
- 338 enrolled
- Eligibility
- All sexes
- Timeline
- 2019 – 2028
Study locations (30)
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Children's Hospital of Orange County, California City, California, United States
- LAC USC Medical Center, Los Angeles, California, United States
- Jackson Memorial Hospital, Miami, Florida, United States
- Tampa General Hospital, Tampa, Florida, United States
- University of Illinois at Chicago, Chicago, Illinois, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- Memorial Hospital of South Bend, South Bend, Indiana, United States
- Norton Children's Hospital, Louisville, Kentucky, United States
- Ochsner Baptist Medical Center, New Orleans, Louisiana, United States
- Tufts Medical Center, Boston, Massachusetts, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Children's Minnesota - Children's Hospital and Clinics - St. Paul, Saint Paul, Minnesota, United States
- Children's Minnesota - Children's Hospital and Clinics, Saint Paul, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03253263 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGNCT07134387Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)Global Foundation for the Care of Newborn Infants